279 related articles for article (PubMed ID: 12176975)
1. Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production.
Xu J; Xiao G; Trujillo C; Chang V; Blanco L; Joseph SB; Bassilian S; Saad MF; Tontonoz P; Lee WN; Kurland IJ
J Biol Chem; 2002 Dec; 277(52):50237-44. PubMed ID: 12176975
[TBL] [Abstract][Full Text] [Related]
2. PPARalpha governs glycerol metabolism.
Patsouris D; Mandard S; Voshol PJ; Escher P; Tan NS; Havekes LM; Koenig W; März W; Tafuri S; Wahli W; Müller M; Kersten S
J Clin Invest; 2004 Jul; 114(1):94-103. PubMed ID: 15232616
[TBL] [Abstract][Full Text] [Related]
3. Hepatic de novo synthesis of glucose 6-phosphate is not affected in peroxisome proliferator-activated receptor alpha-deficient mice but is preferentially directed toward hepatic glycogen stores after a short term fast.
Bandsma RH; Van Dijk TH; Harmsel At At; Kok T; Reijngoud DJ; Staels B; Kuipers F
J Biol Chem; 2004 Mar; 279(10):8930-7. PubMed ID: 14688286
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ
Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878
[TBL] [Abstract][Full Text] [Related]
5. A role for mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) in the regulation of hepatic gluconeogenesis.
Stark R; Guebre-Egziabher F; Zhao X; Feriod C; Dong J; Alves TC; Ioja S; Pongratz RL; Bhanot S; Roden M; Cline GW; Shulman GI; Kibbey RG
J Biol Chem; 2014 Mar; 289(11):7257-63. PubMed ID: 24497630
[TBL] [Abstract][Full Text] [Related]
6. A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase.
Campbell FM; Kozak R; Wagner A; Altarejos JY; Dyck JR; Belke DD; Severson DL; Kelly DP; Lopaschuk GD
J Biol Chem; 2002 Feb; 277(6):4098-103. PubMed ID: 11734553
[TBL] [Abstract][Full Text] [Related]
7. Evidence against the peroxisome proliferator-activated receptor alpha (PPARalpha) as the mediator for polyunsaturated fatty acid suppression of hepatic L-pyruvate kinase gene transcription.
Pan DA; Mater MK; Thelen AP; Peters JM; Gonzalez FJ; Jump DB
J Lipid Res; 2000 May; 41(5):742-51. PubMed ID: 10787435
[TBL] [Abstract][Full Text] [Related]
8. Reduced hepatic fatty acid oxidation in fasting PPARalpha null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression.
Le May C; Pineau T; Bigot K; Kohl C; Girard J; Pégorier JP
FEBS Lett; 2000 Jun; 475(3):163-6. PubMed ID: 10869548
[TBL] [Abstract][Full Text] [Related]
9. Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase.
Burgess SC; Hausler N; Merritt M; Jeffrey FM; Storey C; Milde A; Koshy S; Lindner J; Magnuson MA; Malloy CR; Sherry AD
J Biol Chem; 2004 Nov; 279(47):48941-9. PubMed ID: 15347677
[TBL] [Abstract][Full Text] [Related]
10. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance.
Guerre-Millo M; Rouault C; Poulain P; André J; Poitout V; Peters JM; Gonzalez FJ; Fruchart JC; Reach G; Staels B
Diabetes; 2001 Dec; 50(12):2809-14. PubMed ID: 11723064
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db Mice.
Im SS; Kim MY; Kwon SK; Kim TH; Bae JS; Kim H; Kim KS; Oh GT; Ahn YH
J Biol Chem; 2011 Jan; 286(2):1157-64. PubMed ID: 21081500
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.
Kersten S; Seydoux J; Peters JM; Gonzalez FJ; Desvergne B; Wahli W
J Clin Invest; 1999 Jun; 103(11):1489-98. PubMed ID: 10359558
[TBL] [Abstract][Full Text] [Related]
13. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
Hashimoto T; Cook WS; Qi C; Yeldandi AV; Reddy JK; Rao MS
J Biol Chem; 2000 Sep; 275(37):28918-28. PubMed ID: 10844002
[TBL] [Abstract][Full Text] [Related]
14. Alterations in carbohydrate metabolism and its regulation in PPARalpha null mouse hearts.
Gélinas R; Labarthe F; Bouchard B; Mc Duff J; Charron G; Young ME; Des Rosiers C
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1571-80. PubMed ID: 18223187
[TBL] [Abstract][Full Text] [Related]
15. Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice.
Cotter DG; Ercal B; d'Avignon DA; Dietzen DJ; Crawford PA
Am J Physiol Endocrinol Metab; 2014 Jul; 307(2):E176-85. PubMed ID: 24865983
[TBL] [Abstract][Full Text] [Related]
16. Elevated tissue omega-3 fatty acid status prevents age-related glucose intolerance in fat-1 transgenic mice.
Romanatto T; Fiamoncini J; Wang B; Curi R; Kang JX
Biochim Biophys Acta; 2014 Feb; 1842(2):186-91. PubMed ID: 24211484
[TBL] [Abstract][Full Text] [Related]
17. Influence of conjugated linoleic acid on body composition and target gene expression in peroxisome proliferator-activated receptor alpha-null mice.
Peters JM; Park Y; Gonzalez FJ; Pariza MW
Biochim Biophys Acta; 2001 Oct; 1533(3):233-42. PubMed ID: 11731333
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor alpha deficiency modifies glucose handling by isolated mouse adipocytes.
Walker CG; Sugden MC; Gibbons GF; Holness MJ
J Endocrinol; 2007 Apr; 193(1):39-43. PubMed ID: 17400801
[TBL] [Abstract][Full Text] [Related]
19. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).
Aoyama T; Peters JM; Iritani N; Nakajima T; Furihata K; Hashimoto T; Gonzalez FJ
J Biol Chem; 1998 Mar; 273(10):5678-84. PubMed ID: 9488698
[TBL] [Abstract][Full Text] [Related]
20. Peroxisomal proliferator-activated receptor alpha deficiency diminishes insulin-responsiveness of gluconeogenic/glycolytic/pentose gene expression and substrate cycle flux.
Xu J; Chang V; Joseph SB; Trujillo C; Bassilian S; Saad MF; Lee WN; Kurland IJ
Endocrinology; 2004 Mar; 145(3):1087-95. PubMed ID: 14670991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
